Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Global X Genomics & Biotechnology ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GNOM.
Open | $8.17 |
High | $8.31 |
52 Wk High | $11.88 |
AUM | 43.59M |
Dividend | - |
Ex-Div Date | - |
Volume | 34.57K |
Market Cap | $18.23B |
Mgmt Fee | 0.5% |
P/E Ratio | 46.11 |
Prev. Close | $8.18 |
Low | $8.12 |
52 Wk Low | $6.80 |
Shares Out | 9.12M |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | 55.27K |
Beta | 1.13 |
Avg. Expense Ratio | 0.5% |
P/B Ratio | 2.89 |
You can purchase shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) through any online brokerage.
There are no as such competitors for Global X Genomics & Biotechnology ETF.
There is no analysis for Global X Genomics & Biotechnology ETF to provide a consensus price target.
The stock price for Global X Genomics & Biotechnology ETF (NASDAQ: GNOM) is $8.27 last updated June 13, 2025 at 9:30 AM EDT.
There are no upcoming dividends for Global X Genomics & Biotechnology ETF.
Global X Genomics & Biotechnology ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Global X Genomics & Biotechnology ETF.
Open | $8.17 |
High | $8.31 |
52 Wk High | $11.88 |
AUM | 43.59M |
Dividend | - |
Ex-Div Date | - |
Volume | 34.57K |
Market Cap | $18.23B |
Mgmt Fee | 0.5% |
P/E Ratio | 46.11 |
Prev. Close | $8.18 |
Low | $8.12 |
52 Wk Low | $6.80 |
Shares Out | 9.12M |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | 55.27K |
Beta | 1.13 |
Avg. Expense Ratio | 0.5% |
P/B Ratio | 2.89 |
Sector | Healthcare |
Category | Mid Performer-Mid Growth |
Investment Style | Mid Cap Growth |
Fund Inception | Apr 5, 2019 |
Managers | Nam To Sandy Lu Wayne Xie Vanessa Yang |
Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
ALNY | Alnylam Pharmaceutical... | 5.13% |
RNA | Avidity Biosciences In... | 4.54% |
TECH | Bio-Techne Corp | 4.04% |
LEGN | Legend Biotech Corp | 4.12% |
ARWR | Arrowhead Pharmaceutic... | 4.43% |
NTLA | Intellia Therapeutics ... | 4.19% |
MYGN | Myriad Genetics Inc | 4.08% |
SRPT | Sarepta Therapeutics I... | 3.94% |
NTRA | Natera Inc | 4.58% |
MRNA | Moderna Inc | 4.18% |
VCYT | Veracyte, Inc. | 4.88% |
A | Agilent Technologies I... | 4.27% |
FF | Biontech Se Adr | 4.92% |
SG | Qiagen N.V. | 4.39% |
ILMN | Illumina, Inc. | 4.43% |
BMRN | Biomarin Pharmaceutica... | 4.78% |
SM | Crispr Therapeutics Ag | 4.01% |
BEAM | Beam Therapeutics Inc | 4.17% |
HK | Genscript Biotech Corp | 4.23% |
GH | Guardant Health Inc | 4.25% |
RARE | Ultragenyx Pharmaceuti... | 3.99% |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.